• Treating blood cancers, like ALL and MCL, with CAR-T cells

    Find out how researchers at Baylor Scott & White Health are engineering CAR-T to recognize specific antigens located on the surface of targeted cancer cells.

  • Grant funds research for early pancreatic cancer detection

    We recently received a $5.13 million national grant to fund research seeking to detect pancreatic cancer early by testing just a small sample of the patient’s blood.

  • Revisiting the danger of contrast-induced acute kidney injury

    Recent investigation into the potential cause of acute kidney injury after PCI and intervention may alter the accepted clinical belief that contrast media is the culprit.

Our people are at the forefront of health care

Why Baylor Scott & White Health

We’ve created a transformative model for the health care industry that eliminates waste, improves coordination of care and helps us better manage chronic disease.

Medical Education

Baylor Scott & White has both clinical and research campuses for the Texas A&M Health Science Center (HSC) College of Medicine. In addition, we are an accredited provider for the Accreditation Council for Continuing Medical Education (ACCME).

Our Departments

Our extensive network of 48 hospitals and more than 900 patient care sites – including specialized centers, institutes and regional clinics – offers your patients a full range of medical expertise.

Innovation with a commitment to every patient

Management of complex regional pain syndrome

We define features of complex regional pain syndrome in a 35-year-old patient, outline its treatment options and describe a course of CRPS management.

ADvance Research & Care Symposium

Register for this forward facing event featuring breakthroughs in biomarkers, imaging and prevention of Alzheimer's disease.

Chronic migraine clinical trial

We currently have a study comparing the effectiveness, safety and tolerability of SAR341402, insulin aspart, with that of the currently marketed insulin analog insulin aspart.